Evofem Biosciences, Inc. revenue decreases to $16.84 million in 2022 from previous year
Key fundamental financials- loss of $76.70 million
- Revenue of $16.84 million
By USInMinutes
Published - Apr 27, 2023, 05:50 PM ET
Last Updated - Jul 18, 2023, 03:47 PM EDT
| Current Reporting | Revenue | Net Income | Profit/Loss |
|---|---|---|---|
| Dec 2022 | $16.84 million | $76.70 million | loss |
| Dec 2021 | $8.24 million | $205.19 million | loss |
| Dec 2020 | $446,000 | $142.31 million | loss |
Evofem Biosciences, Inc. [EVFM] has reported $76.70 million loss for the fiscal year ending Dec 31, 2022.
Revenue for the year was $16.84 million with operating income of $84.12 million.
The Sandiego, California (CA)-based company operating in the pharmaceutical preparations sector.
This is a developing story. Click here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.
Our Offices
10kInfo, Inc.
13555 SE 36th St
Bellevue, WA 9800610kInfo Data Solutions, Pvt Ltd.
Claywork Create
11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
Bengaluru, Karnataka 560076
4.2 12182024
Popular News
